Andrew Reardon - 10 Aug 2025 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
CLO & Secretary
Signature
/s/ Andrew Reardon
Issuer symbol
LGND
Transactions as of
10 Aug 2025
Net transactions value
-$198,830
Form type
4
Filing time
12 Aug 2025, 16:34:53 UTC
Previous filing
02 Jul 2025
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reardon Andrew CLO & Secretary 555 HERITAGE DRIVE, SUITE 200, JUPITER /s/ Andrew Reardon 12 Aug 2025 0001950232

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability $198,830 -1,325 -4.1% $150.06 30,811 10 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.